Please sign in to follow a disease.
Autoimmune polyendocrinopathy type 2
MONDO:0010012Autoimmune polyglandular syndrome of likely polygenic etiology characterized by the presence of primary adrenal insufficiency in association with autoimmune thyroiditis and/or type 1 diabetes mellitus; this condition is not associated with mucocutaneous candidiasis.
Also known as: APS type 2, APS2, Autoimmune Polyendocrine Syndrome Type II, Schmidt syndrome, autoimmune polyendocrine syndrome type 2, autoimmune polyglandular syndrome type 2, autoimmune thyroid disease and/or type 1 diabetes-Addison disease syndrome, APS 2
43 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Biopsy tolerance study ends early – what we know
Knowledge-focused TerminatedThis study aimed to understand how well patients tolerate biopsies for autoimmune diseases and whether they feel properly informed. It planned to enroll 505 people but was terminated early. The results may help improve patient experience with these common procedures.
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Yeast study in rare autoimmune disease terminated early
Knowledge-focused TerminatedThis study aimed to compare the types of Candida yeast found in patients with two forms of autoimmune polyendocrinopathy, a rare condition where the immune system attacks multiple glands. Researchers planned to collect samples from the mouth and urine of 7 participants to see how…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC